Importantly, as in the case of TNF-α receptors levels in RA patients, the baseline percentages of Th1 and Th17 lymphocytes expressing TNFR1 and TNFR2 did not change upon therapeutic neutralization of TNF-α (Figure 7B,D, respectively). The gene discussed is TNFRSF1A; the disease is rheumatoid arthritis.